Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

HKG:3737 Revenue

Zhongzhi Pharmaceutical Holdings had revenue of 789.96M CNY in the half year ending June 30, 2026, a decrease of -27.42%. This brings the company's total for the last twelve months to 1.65B, down -17.93% year-over-year. In the year 2025, Zhongzhi Pharmaceutical Holdings had annual revenue of 1.74B, down -21.55%. That makes Zhongzhi Pharmaceutical Holdings the 16,070th largest company in the world by revenue and 940th in Hong Kong.

• Revenue (ttm): 1.65B CNY
• Revenue Growth: -17.93%
• P/S Ratio: 0.28
• Revenue / Employee: 759.67K CNY
• Employees: 2,168
• Market Cap: 539.75M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 1.80B 77.3%
• Operation of Chain Pharmacies 528.81M 22.7%

Fiscal year ended Dec 31, 2025 See the full HKG:3737 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.74B	-477.30M	-21.55%
Dec 31, 2024	2.21B	164.97M	8.05%
Dec 31, 2023	2.05B	223.88M	12.26%
Dec 31, 2022	1.83B	79.44M	4.55%
Dec 31, 2021	1.75B	142.62M	8.89%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error